Bronchiolitis obliterans syndrome in lung transplant recipients;Bronchiolitis obliterans szindróma a tüdotranszplantá ción átesett betegekben

Orvosi Hetilap

Volumn 146, Issue 19, 2005, Pages 953-958

  Antus, Balázs ^a,b   Fillinger, János ^a   Csiszér, Eszter ^a   Czebe, Krisztina ^a   Horváth, Ildikó ^a  

^a Orszagos Koranyi Tbc es Pulmonologiai Intezet   (Hungary)

^b NONE   (Hungary)

Author keywords

Bronchiolitis obliterans syndrome; Growth factors; Lung function tests; Lung transplantation; Pathophysiology; Risk factors; Staging

Indexed keywords

ALLOANTIGEN; CYTOKINE; GROWTH FACTOR; MATRIX PROTEIN;

ALLOIMMUNITY; BRONCHIOLITIS OBLITERANS; CELL PROLIFERATION; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; FIBROBLAST; GASTROESOPHAGEAL REFLUX; GRAFT RECIPIENT; GRAFT REJECTION; HISTOCOMPATIBILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG FUNCTION; LUNG TRANSPLANTATION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN SYNTHESIS; REPERFUSION INJURY; RESPIRATORY EPITHELIUM; REVIEW; RISK FACTOR; SMOOTH MUSCLE FIBER; SYMPTOM; T LYMPHOCYTE; ANIMAL; DISEASE MODEL; LUNG FUNCTION TEST; METABOLISM; PATHOLOGY;

ANIMALS; BRONCHIOLITIS OBLITERANS; DISEASE MODELS, ANIMAL; HUMANS; LUNG TRANSPLANTATION; RESPIRATORY FUNCTION TESTS; RISK FACTORS;

EID: 22144470807     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Adams B. F., Brazelton T., Berry G. J. és mtsa: The role of the respiratory epithelium in a rat model of obliterative airway disease. Transplantation, 2000, 69, 661-693.
2. Andersen H.: Heart allograft vascular disease. An obliterative vascular disease in transplanted hearts. Atherosclerosis, 1999, 142, 243-263.
3. Aris R. M., Walsh S., Chalermskulrat W. és mtsai: Growth factor upregulation during obliterative bronchiolitis in the mouse model. Am. J. Respir. Crit. Care. Med., 2002, 166, 417-422.
4. Avlonitis, V. S., Krause, A., Luzzi, L., és mtsai: Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation. Eur. J. Cardiothorac. Surg., 2003, 24, 601-607.
5. Boehler, A., Estenne, M.: Post-transplant bronchiolitis obliterans. Eur. Respir. J., 2003, 22, 1007-1018.
6. Boehlr, A., Bai, X. H., Liu, M. és mtsai: Upregulation of T-helper 1 cytokines and chemokines expression in post-transplant airwa obliteration. Am. J. Respir. Crit. Care. Med., 1999, 159, 1910-1917.
7. Cagle, P. T., Brown, R. W., Frost, A. és mtsai: Diagnosis of chronic lung transplant rejection by transbronchial biopsy. Modern. Pathology., 1995, 8, 137-142.
8. Charpin, J. M., Stern, M., Grenet, D. és mtsa: Insulin-like growth factor-1 in lung transplant with obliterative bronchiolitis. Am. J. Respir. Crit. Care. Med., 2000, 161, 1991-1998.
9. Cooper, J. D., Billingham, M., Egan, T. és mtsai: A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J. Heart Lung Transplant., 1993, 12, 713-716.
10. Csiszér E., Barna E., Böszörményi Nagy G. és mtsai: A tüdotranszplantáció indikációi, a betegkiválsztás szempontjai, adminisztratív teendok. Med. Thorac., 2003, 56, 124-128.
11. Davis, R. D. Jr, Lau, C. L., Eubanks, S. és mtsai: Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J. Thorac. Cardiovasc. Surg., 2003, 125, 533-542.
12. De Soyza, A., Fisher, A. J., Small T. és mtsa: Inhaled corticosteroids and the treatment of lymphocytic bronchiolitis following lung transplantation. Am. J. Respir. Crit. Care. Med., 2001, 164, 1209-1212.
13. Elssner, A., Vogelmeier, C.: The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation. Traspl. Infect. Dis., 2001, 3, 168-176.
14. Estenne, M., Maurer, J. R., Boehlr, A. és mtsai: Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J. Heart Lung Transplant., 2002, 21, 297-310.
15. Fiser, S. M., Kron, I. L., Long, S. M. és mtsai: Influence of graft ischemic time on outcomes following lung transplantation. J. Heart Lung Transplant., 2001, 20, 1291-1296.
16. Fiser, S. M., Tribble, C. G., Long, S. M. és mtsai: Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann. Thorac. Surg., 2002, 73, 1041-1047.
17. Hadjiliadis, D., Duane, D., R., Steele, M. P. és mtsai: Gastroesophageal reflux disease in lung transplant recipients. Clin. Transplant., 2003, 17, 363-368.
18. Hele, D. J., Yacoub, H. M., Belvisi, M. G.: The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis. Respir. Res., 2001, 2, 169-183.
19. Hertz, M. I., Henke, C. A., Nakhleh, R. E. ěs mtsai: Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc. Natl. Acad. Sci. USA., 1992, 89, 10385-10389.
20. Hertz, M. I., Taylor, D. O., Trulock, E. P. és mtsai: The registry of the international society for heart and lung transplantation: nineteenth official report-2002. J. Heart. Lung. Transplant., 2002, 21, 950-970.
21. Husian A. N., Siddiqui M. T., Holmes E. W. és mtsai.: Analysis of risk factors for development of bronchiolitis obliterans syndrome. Am. J. Respir. Crit. Care. Med., 1999, 759, 829-833.
22. Iacono, A. T., Keenan, R. J., Duncan, S. R. és mtsai: Aerosolized cyclosporine in lung recipients with refractory chronic rejection. Am. J. Respir. Crit. Care. Med., 1996, 153, 1451-1455.
23. Inomata, Y., Tanaka, K.: Pathogenesis and treatment of bile duct loss after liver transplantation. J. Hepatobiliary. Pancreat. Surg., 2001, 8, 316-322.
24. Jackson C. H., Sharples, L. D., McNeil, K. és mtsai: Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities? J. Heart Lung Transplant., 2002, 21, 658-666.
25. Jaramillo, A., Naziruddin, B., Zhang, L. és mtsai: Activation of human airway epithelial cellc by non-HLA antibodies developed after lung transplantation: a potential etiologic factor for bronchiolitis obliterans syndrome. Transplantation, 2001, 71, 966-976.
26. Jaramillo, A., Smith, M. A., Phelan, D. és mtsai: Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation, 1999, 67, 1155-1161.
27. Kesten, S., Maidenberg, A., Winton, T. és mtsai: Treatment of presumed and proven acute rejection following six months of lung transplant survival. Am. J. Respir. Crit. Care. Med., 1995, 152, 1321-1324.
28. Kesten, S., Rajagopalan, N., Maurer, J.: Cytolytic therapy for the treatment of bronchiolitis obliterans syndrome following lung transplantation. Transplantation, 1996, 61, 427-430.
29. Khalifah, A. P., Hachem, R. R., Chakinala, M. M. és mtsai: Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am. J. Respir. Crit. Care. Med., 2004, 170, 181-187.
30. Koskinen, P. K., Kallio, E. A., Bruggeman, C. A., Leinström, K. B.: Cytomegalovirus infection enhances experimental obliterative bronchiolitis in rat tracheal allografts. Am. J. Respir. Crit. Care. Med., 1997, 155, 2078-2088.
31. Lang G., Vadász P., Agócs L., Csiszér E., Czebe K., Klepetko W.: A tüdotranszplantáció helyzete Magyarországon. LAM., 2003, 13, 452-459.
32. Lau, C. L., Palmer, S. M., Posther, K. E. és mtsai: Influence of panelreactive antibodies on posttransplant outcomes in lung transplant recipients. Ann. Thorac. Surg., 2000, 69, 1520-1524.
33. Maclean, A. A., Liu, M., Fischer, S. és mtsai: Targeting the angiotensin system in posttransplant airway obliteration: the antifibrotic effect of angiotensin converting enzyme inhibition. Am. J. Respir. Crit. Care. Med., 2000, 162, 310-315.
34. Milne, D. S., Gascoigne, A. D., Wilkes, J., és mtsai: MHC class II and ICAM-1 expression and lymphocyte subsets in transbronchial biopsies from lung transplant recipients. Transplantation, 1994, 57, 1762-1766.
35. Nathan, S. D., Ross, D. J., Belman, M. J. és mtsai: Bronchiolitis obliterans in single-lung transplant recipients. Chest, 1995, 107, 967-972.
36. O'Hagan, A. R., Stillwell, P. C., Arroliga, A. és mtsa: Photopheresis in the treatment of refractory bronchiolitis obliterans syndrome. Chest., 1999, 115, 1459-1462.
37. Paul, L. C.: Chronic allograft nephropathy: an update. Kidney. Int., 1999, 56, 783-793.
38. Quantz, M. A., Bennett, L. E., Meyer, D. M. es mtsa: Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3549 lung transplantation. J. Heart Lung Transplant., 2000, 19, 473-479.
39. Reynaud-Gaubert, M., Thomas, P., Badier, M. és mtsai: Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings. Am. J. Respir. Crit. Care. Med., 2000, 161, 1924-1929.
40. Ross, D. J., Marchevsky, A., Kramer, M. és mtsai: Refractoriness of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts. J. Heart. Lung. Transplant., 1997, 16, 832-838.
41. Sarahrudi, K., Estenne, M., Corris, P. és mtsai: International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection. J. Thorac. Cardiovasc. Surg., 2004, 127, 1126-1132.
42. Schulman, L. L., Weinberg, A. D., McGregor, C. C. és mtsai: Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation. Am. J. Respir. Crit. Care. Med., 2001, 163, 437-442.
43. Sharples, L. D., McNeil, K., Stewart, S. és mtsai: Risk factors for bronchiolitis obliterans: a systemic review of recent publications. J. Heart Lung Transplant., 2002, 21, 271-281.
44. Speich, R., Thurnheer, R., Gaspert, A. és mtsai: Efficiency and cost effectiveness of oral ganciclovir in the prevention of cytomegalovirus disease after lung transplantation. Transplantation, 1999, 67, 315-320.
45. Suga, M., Maclean, A. A., Keshavjee, S. és mtsai: RANTES plays an important role in the evolution of allograft transplant-induced fibrous airway obliteration. Am. J. Respir. Crit. Care. Med., 2000, 162, 1940-1948.
46. Tiroke, A. H., Bewig, B., Haverich, A.: Bronchoalveolar lavage in lung transplantation. State of the art. Clin. Transplant., 1999, 13, 131-157.
47. Westall, G. P., Michaelides, A., Williams, T. J. eś mtsai: Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation. Transplantation, 2003, 75, 2064-2068.
48. Zsiray M., Szabó Zs.: Betegek kiválasztása és az idozítés kérdése tü dotranszplantációban. Med. Thorac., 2004, 57, 92-97.